Carboplatin

Back to search
Scientific Name: Carboplatin
Brand Name: Paraplatin
Company Owner: App pharmaceuticals llc, Bedford laboratories div ben venue laboratories inc, Hospira inc, Pliva inc, Sandoz inc, Watson laboratories inc, Watson laboratories, Bristol myers squibb co pharmaceutical research institute, Akorn inc, Bedford laboratories, Bioniche pharma usa llc, Ebewe pharma ges mbh nfg kg, Fresenius kabi oncology plc, Pharmachemie bv, Pliva lachema as, Spectrum pharmaceuticals inc, Sun pharma global inc, Teva parenteral medicines inc, Bristol myers squibb co
Mechanism Of Action Carboplatin predominantly acts by attaching alkyl groups to the nucleotides, leading to the formation of monoadducts, and DNA fragmenting when repair enzymes attempt to correct the error.
Description of the Drug: Carboplatin is a alkylating agent used to treat advanced ovarian cancer.
Protein Data Bank: Not Available
Source: DrugBank Online – DrugBank.com. Retrieved 2023-01-23 from https://go.drugbank.com/drugs/DB00958